KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Charles River Laboratories International (CRL) Leases: 2019-2025

Historic Leases for Charles River Laboratories International (CRL) over the last 7 years, with Sep 2025 value amounting to $374.3 million.

  • Charles River Laboratories International's Leases fell 2.82% to $374.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $374.3 million, marking a year-over-year decrease of 2.82%. This contributed to the annual value of $412.5 million for FY2024, which is 4.69% up from last year.
  • As of Q3 2025, Charles River Laboratories International's Leases stood at $374.3 million, which was down 2.98% from $385.8 million recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Leases peaked at $412.5 million during Q4 2024, and registered a low of $197.7 million during Q1 2021.
  • Moreover, its 3-year median value for Leases was $386.1 million (2024), whereas its average is $391.5 million.
  • Its Leases has fluctuated over the past 5 years, first soared by 69.10% in 2021, then decreased by 5.89% in 2024.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Leases stood at $292.9 million in 2021, then surged by 33.73% to $391.8 million in 2022, then rose by 0.58% to $394.0 million in 2023, then climbed by 4.69% to $412.5 million in 2024, then declined by 2.82% to $374.3 million in 2025.
  • Its Leases stands at $374.3 million for Q3 2025, versus $385.8 million for Q2 2025 and $402.9 million for Q1 2025.